RxDoctor Payments Data

Colleen Little, DO

Family Medicine · Bridgewater, NJNPI 1093194904

Payments from drug & device makers

$2,718in general payments, 2019–2025

Across 166 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$563
  • Pfizer$338
  • AbbVie$272
  • AstraZeneca$269
  • GSK$206
  • Boehringer Ingelheim$190
  • plus $881 from 23 others

What the payments were for

  • Food & beverage$2,718100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,718 in reported general payments places this provider in the 80th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$38,073
Medicare patients
155
Services billed
588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol39$36,213
OzempicSemaglutide16$21,507
MounjaroTirzepatide17$17,980
RybelsusSemaglutide11$14,322
Rosuvastatin Calcium127$2,919
Atorvastatin Calcium38$524
Levothyroxine Sodium44$469
Losartan Potassium25$316
Lisinopril46$285
Gabapentin11$282
Tamsulosin Hcl14$276
Amlodipine Besylate35$261
Amlodipine-ValsartanAmlodipine Besylate/Valsartan16$245
Metoprolol Succinate22$241
Pioglitazone Hcl21$216

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$269$36,21339 claims
Novo NordiskOzempic, Rybelsus$563$35,82927 claims
Lilly USA, LLCMounjaro$125$17,98017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Bridgewater

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →